Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Abstract

These results do not support the routine use of intravenous milrinone as an adjunct to standard therapy in the treatment of patients hospitalized for an exacerbation of chronic heart failure.